Q1 revenue growth of 14% year-over-year Q1 net income of $29.3 million and non-GAAP net income of $58.7 million Q1 net income margin of 11%; adjusted EBITDA margin of 42% Raising revenue and adjusted EBITDA guidance for 2025 LEHI, Utah and LOUISVILLE, Ky., April 30, 2025 /PRNewswire/ –…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
TEL AVIV, Israel & LEHI, Utah–(BUSINESS WIRE)– #MyHeritage–MyHeritage Launches 3rd DNA Quest Initiative to Help Adoptees Find Their Birth Families. Click here to view original post
SAN FRANCISCO, June 4, 2023 /PRNewswire/ — Vial, a global tech-first CRO providing next-generation clinical trial management services, announced it will be sponsoring and presenting at the 2023 Clinical Trials at the Summit (CTS) in […]
Funds will support the advancement of lead programs in Phase II clinical trials, evaluating HT-6184, Halia’s first-in-class NLRP3/NEK7 inflammasome inhibitor, and advancing additional programs into the clinic. LEHI, Utah, Jan. 31, 2024 /PRNewswire/ — Halia […]
Copyright © 2026 Biotech Networks
